<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03435315</url>
  </required_header>
  <id_info>
    <org_study_id>2018P000014</org_study_id>
    <nct_id>NCT03435315</nct_id>
  </id_info>
  <brief_title>Treadmill Exercise in Metabolic Syndrome</brief_title>
  <official_title>Treadmill Exercise in Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to better understand the effects of two types of treadmill
      exercise programs that include education and/or techniques that may be helpful for exercise
      among individuals with, or at risk for, metabolic syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment Feasibility</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>% willing to be randomized</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Protocol Adherence</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>% sessions attended</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary Dynamics</measure>
    <time_frame>Weeks 1, 4, and 8</time_frame>
    <description>CardioPulmonary Exercise Testing (standard metabolic cart)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Fatigue Severity Scale-7; total score range: 7-49, higher scores = greater fatigue severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Health</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>PROMIS Global Health-10; Global physical health total score range: 4-20, higher scores = better global physical health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological Symptoms</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Depression Anxiety and Stress Scale-21; Depression total score range: 0-21, higher scores = greater depressive symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Affect</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Positive and Negative Affect Schedule; 2 subscales; each with score range 10-50, higher = greater positive or negative affect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety Sensitivity</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Anxiety Sensitivity Index-3; Total score range: 0-72, higher scores = higher levels of anxiety sensitivity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distress Tolerance</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Distress Tolerance Scale; total score range: 15-75, higher scores = higher levels of distress tolerance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort Intolerance</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Discomfort Intolerance Scale-Revised; total score range: 0-126, higher scores = higher levels of discomfort intolerance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Acceptance</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Physical Activity Acceptance Questionnaire; total score range: 10-70, higher scores = greater physical activity acceptance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Self-Efficacy</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Multidimensional Self-Efficacy Scale; total score range: 0-90, higher scores = higher levels of exercise self-efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Motivation</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Behavioral Regulation towards Exercise Questionnaire-2; 5 subscales, each with score range: 0-16, higher scores = higher levels of regulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Barriers</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Exercise Benefits and Barriers Scale; 2 subscales; Exercise benefits subscale score range: 29-116, higher scores = higher perceived benefit from exercise; Exercise barriers subscale score range: 14-56, higher scores = higher perceived barriers to exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Godin Leisure Time Exercise Questionnaire; open-ended responses, higher scores = greater activity time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trait Mindfulness</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Five Facet Mindfulness Questionnaire; 5 subscales; Observe subscale score range: 8-40, higher scores = greater observing skills; Describe subscale score range: 8-40, higher scores = greater describing skills; Acting with Awareness subscale score range: 8-40, higher scores = greater awareness skills; Nonjudgment subscale score range: 8-40, higher scores = greater nonjudgment skills; Nonreactivity subscale score range: 7-35, higher scores = greater nonreactivity skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State Mindfulness</measure>
    <time_frame>Weeks 1, 4, 8</time_frame>
    <description>State Mindfulness Scale for Physical Activity; 2 subscales, each with score range: 0-24, higher scores = higher levels of mindfulness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interoceptive Awareness</measure>
    <time_frame>Week 0, week 4, week 9</time_frame>
    <description>Multidimensional Assessment of Interoceptive Awareness; 8 subscales, each with score ranges: 0-5, higher scores = better</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Treadmill exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Treadmill exercise with behavioral techniques</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treadmill Exercise- behavioral approach</intervention_name>
    <description>16-session, 8-week treadmill exercise program utilizing behavioral techniques while walking</description>
    <arm_group_label>Treadmill exercise with behavioral techniques</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treadmill Exercise- traditional approach</intervention_name>
    <description>16-session, 8-week traditional treadmill exercise program</description>
    <arm_group_label>Treadmill exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Referred by healthcare provider and given medical clearance for moderate-intensity
             exercise

          2. At risk for metabolic syndrome, defined as meeting two or more of the following
             criteria:

               -  Obesity or overweight defined as BMI &gt; 25

               -  Impaired glycemia (fasting blood sugar of ≥ 100 [5.6 mmol/L] or glycated
                  hemoglobin [A1C] of ≥ 5.7)

               -  Increased blood pressure (130/85 mmHg or higher) or if you take medicine for high
                  blood pressure

               -  Increased fasting levels of triglycerides (≥ 150 or 1.7 mmol/L) or decreased
                  fasting high-density lipoprotein (HDL) cholesterol (less than 40 mg/dL or 1
                  mmol/L for men or 50 mg/dL or 1.3 mmol/L for women) or if you take any medicines
                  for dyslipidemia

          3. Between the ages of 18-65

          4. No regular physical activity (≥ 3 or more days per week) for the past 3 months

        Exclusion Criteria:

          1. Contraindications for treadmill exercise determined by their physician (e.g.,
             cardiopulmonary limitations or diagnoses) or other inability to do treadmill exercise
             (e.g., musculoskeletal restrictions or severe balance impairment)

          2. Confirmed diagnosis of coronary artery disease

          3. Confirmed diagnosis of diabetes

          4. Currently taking a beta blocker or calcium channel blocker medication

          5. Uncontrolled and untreated hypertension, defined as a resting blood pressure of 150/90

          6. Confirmed diagnosis of chronic obstructive pulmonary disease or other severe lung
             dysfunction that may interfere with exercise (e.g., severe asthma)

          7. Self-reported psychotic disorder

          8. Current practice of mindfulness mediation or mindful movement (e.g., yoga or tai chi),
             defined as regular daily practice or &gt;2 classes or self-guided sessions per week in
             the past three months.

          9. Non-English speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gloria Yeh, MD, MPH</last_name>
    <phone>617-754-1419</phone>
    <email>gyeh@bidmc.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristen Kraemer, PhD</last_name>
    <phone>617-7541443</phone>
    <email>kkraemer@bidmc.harvard.edu</email>
  </overall_contact_backup>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2018</study_first_submitted>
  <study_first_submitted_qc>February 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2018</study_first_posted>
  <last_update_submitted>February 9, 2018</last_update_submitted>
  <last_update_submitted_qc>February 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Gloria Y. Yeh</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

